Correlation
The correlation between BIO and TMO is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
BIO vs. TMO
Compare and contrast key facts about Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIO or TMO.
Performance
BIO vs. TMO - Performance Comparison
Loading data...
Key characteristics
BIO:
-0.50
TMO:
-1.05
BIO:
-0.53
TMO:
-1.67
BIO:
0.94
TMO:
0.80
BIO:
-0.28
TMO:
-0.76
BIO:
-1.09
TMO:
-1.91
BIO:
19.02%
TMO:
16.04%
BIO:
40.38%
TMO:
27.28%
BIO:
-76.26%
TMO:
-71.16%
BIO:
-72.44%
TMO:
-38.98%
Fundamentals
BIO:
$6.29B
TMO:
$152.34B
BIO:
-$76.54
TMO:
$17.01
BIO:
1.19
TMO:
1.55
BIO:
2.48
TMO:
3.55
BIO:
0.93
TMO:
3.07
BIO:
$2.54B
TMO:
$42.90B
BIO:
$1.36B
TMO:
$17.83B
BIO:
-$2.52B
TMO:
$10.60B
Returns By Period
In the year-to-date period, BIO achieves a -30.71% return, which is significantly lower than TMO's -22.32% return. Over the past 10 years, BIO has underperformed TMO with an annualized return of 4.69%, while TMO has yielded a comparatively higher 12.38% annualized return.
BIO
-30.71%
-6.07%
-32.76%
-20.14%
-25.35%
-14.26%
4.69%
TMO
-22.32%
-5.56%
-22.48%
-28.62%
-10.75%
3.20%
12.38%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BIO vs. TMO — Risk-Adjusted Performance Rank
BIO
TMO
BIO vs. TMO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
BIO vs. TMO - Dividend Comparison
BIO has not paid dividends to shareholders, while TMO's dividend yield for the trailing twelve months is around 0.40%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIO Bio-Rad Laboratories, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TMO Thermo Fisher Scientific Inc. | 0.40% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% | 0.48% |
Drawdowns
BIO vs. TMO - Drawdown Comparison
The maximum BIO drawdown since its inception was -76.26%, which is greater than TMO's maximum drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for BIO and TMO.
Loading data...
Volatility
BIO vs. TMO - Volatility Comparison
Bio-Rad Laboratories, Inc. (BIO) has a higher volatility of 15.18% compared to Thermo Fisher Scientific Inc. (TMO) at 11.67%. This indicates that BIO's price experiences larger fluctuations and is considered to be riskier than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
BIO vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BIO vs. TMO - Profitability Comparison
BIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bio-Rad Laboratories, Inc. reported a gross profit of 306.00M and revenue of 585.40M. Therefore, the gross margin over that period was 52.3%.
TMO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Thermo Fisher Scientific Inc. reported a gross profit of 4.24B and revenue of 10.36B. Therefore, the gross margin over that period was 40.9%.
BIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bio-Rad Laboratories, Inc. reported an operating income of 23.70M and revenue of 585.40M, resulting in an operating margin of 4.1%.
TMO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Thermo Fisher Scientific Inc. reported an operating income of 1.72B and revenue of 10.36B, resulting in an operating margin of 16.6%.
BIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bio-Rad Laboratories, Inc. reported a net income of 64.00K and revenue of 585.40M, resulting in a net margin of 0.0%.
TMO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Thermo Fisher Scientific Inc. reported a net income of 1.51B and revenue of 10.36B, resulting in a net margin of 14.5%.